Hepatitis C cannot be eliminated in the United States without reaching groups that are most impacted by the epidemic. Incarcerated or formerly incarcerated individuals bear a disproportionate burden of HCV with current estimates putting the prevalence in jails and prisons between 12 and 35 percent. Despite the high prevalence, most inmates with chronic HCV are unaware of their status. Screening and linking incarcerated individuals to care while incarcerated or upon release is essential to ensure they have access to a cure.
Join NASTAD’s Hepatitis Testing Partnership for a webinar on Tuesday June 26, 2018 at 2:00 PM ET to explore strategies for HCV testing and linkage to care for people currently in or transitioning from jail. The Hepatitis Testing Partnership will host a second webinar on strategies focused on prison later in the summer.